LABORATORY RESEARCH SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C Activity To investigate the physiological functions of SIRT2 in development and tumorigenesis, scientists disrupted Sirt2 in mice. [Cancer Cell] Abstract | Press Release Estrogen Receptor–Co-Factor–Chromatin Specificity in the Transcriptional Regulation of Breast Cancer Here, researchers present the most comprehensive chromatin-binding landscape of estrogen receptor α co-regulatory proteins to date. [EMBO J] Abstract Subtype and Pathway Specific Responses to Anticancer Compounds in Breast Cancer In a test of 77 therapeutic compounds, nearly all drugs showed differential responses across different breast cancer cell lines, and approximately one third showed subtype-, pathway-, and/or genomic aberration-specific responses. [Proc Natl Acad Sci USA] Abstract Estrogen Induces Apoptosis in Estrogen Deprivation-Resistant Breast Cancer through Stress Responses as Identified by Global Gene Expression Across Time Data indicates that 17β-estradiol induced apoptosis through endoplasmic reticulum stress and inflammatory responses in advanced antihormone-resistant breast cancer. [Proc Natl Acad Sci USA] Abstract Lactoferrin-Endothelin-1 Axis Contributes to the Development and Invasiveness of Triple Negative Breast Cancer Phenotypes Here investigators discovered that lactoferrin efficiently downregulates the levels of ERα, PR and HER-2 receptors in a proteasome-dependent manner in breast cancer cells, and accounts for the loss of responsiveness to ER- or HER-2- targeted therapies. [Cancer Res] Abstract Overexpressed hPTTG1 Promotes Breast Cancer Cell Invasion and Metastasis by Regulating GEF-H1/RhoA Signaling Here, scientists showed that Rho guanine nucleotide exchange factor-H1 (GEF-H1) was transcriptionally activated by human pituitary tumor-transforming gene 1 (hPTTG1), thereby promoting breast cancer metastasis. [Oncogene] Abstract CERT Depletion Predicts Chemotherapy Benefit and Mediates Cytotoxic and Polyploid-Specific Cancer Cell Death through Autophagy Induction Using an integrative functional genomics approach, researchers find that CERT-specific multidrug sensitization is associated with enhanced autophagosome–lysosome flux, resulting from the expression of LAMP2 following CERT silencing in colorectal and HER2+ breast cancer cell lines. [J Pathol] Abstract | Press Release Functional Implications of Structural Predictions for Alternative Splice Proteins Expressed in Her2/Neu–Induced Breast Cancers Here investigators exploit the state-of-the-art structure prediction method I-TASSER to analyze the structural and functional consequences of alternative splicing of proteins differentially expressed in a breast cancer model. [J Proteome Res] Abstract CLINICAL RESEARCH Risk of Recurrence and Chemotherapy Benefit for Patients with Node-Negative, Estrogen Receptor–Positive Breast Cancer: Recurrence Score Alone and Integrated with Pathologic and Clinical Factors Adding clinicopathologic measures did not seem to enhance the value of recurrence score (RS) alone nor the individual biology RS identified in predicting chemotherapy benefit. [J Clin Oncol] Abstract | Press Release Characteristics of Triple-Negative Breast Cancer in Patients with a BRCA1 Mutation: Results from a Population-Based Study of Young Women Scientists tested whether there are distinguishing features of triple-negative breast cancer after BRCA1 mutation status has been taken into account. [J Clin Oncol] Abstract Adjuvant Sequencing of Tamoxifen and Anastrozole Is Superior to Tamoxifen Alone in Postmenopausal Women with Low Proliferating Breast Cancer The purpose of this study is to assess the predictive value of Ki67 expression in postmenopausal hormone receptor-positive early breast cancer patients who were either treated with adjuvant tamoxifen (TAM) alone or with TAM followed by anastrozole. [Clin Cancer Res] Abstract |